C4 Therapeutics Inc. (CCCC)

C4 Therapeutics Inc. (CCCC) – FDA

Dec 12, 2023 04:01 PM C4 Therapeutics (CCCC) Reports Positive Data from CFT7455 Phase 1 Trial
Dec 12, 2023 07:00 AM C4 Therapeutics Inc. (CCCC) Announces License and Research Collaboration with Merck to Discover and Develop Degrader-Antibody Conjugates
Oct 11, 2023 07:01 AM
Jul 5, 2023 07:01 AM
May 30, 2023 07:10 AM
Sep 29, 2022 07:01 AM
Apr 8, 2022 01:16 PM
Mar 9, 2022 08:00 AM
May 26, 2021 07:00 AM
Apr 12, 2021 06:08 AM
Jan 19, 2021 07:01 AM